These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10565252)

  • 1. The prediction of interferon-alpha therapeutic effect by sequence variation of the HCV hypervariable region 1.
    Yeh BI; Kim HW; Kim HS; Lee JY; Lee KH; Lee KM; Kim JS; Han KH
    Yonsei Med J; 1999 Oct; 40(5):430-8. PubMed ID: 10565252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predictive of response to interferon-alpha therapy in hepatitis C virus type 1b infection.
    Yeh BI; Han KH; Lee HW; Sohn JH; Ryu WS; Yoon DJ; Yoon J; Kim HW; Kong ID; Chang SJ; Choi JW
    J Med Virol; 2002 Apr; 66(4):481-7. PubMed ID: 11857525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy.
    Yeh BI; Han KH; Oh SH; Kim HS; Hong SH; Oh SH; Kim YS
    J Med Virol; 1996 Jun; 49(2):95-102. PubMed ID: 8991943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations.
    Durante Mangoni E; Forton DM; Ruggiero G; Karayiannis P
    J Med Virol; 2003 May; 70(1):62-73. PubMed ID: 12629645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
    N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene.
    Sakuma I; Enomoto N; Kurosaki M; Izumi N; Marumo F; Sato C
    J Infect Dis; 1999 Oct; 180(4):1001-9. PubMed ID: 10479124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies.
    De Mitri MS; Mele L; Morsica G; Chen CH; Sitia G; Gramenzi A; Andreone P; Alberti A; Bernardi M; Pisi E
    J Med Virol; 2000 Feb; 60(2):133-8. PubMed ID: 10596011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy.
    Nagasaka A; Hige S; Tsunematsu I; Yoshida J; Sasaki Y; Matsushima T; Asaka M
    J Med Virol; 1996 Nov; 50(3):214-20. PubMed ID: 8923285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
    von Wagner M; Lee JH; Rüster B; Kronenberger B; Sarrazin C; Roth WK; Zeuzem S
    J Viral Hepat; 2003 Nov; 10(6):413-22. PubMed ID: 14633173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between interferon therapy and variability in nonstructural gene 5b of hepatitis C virus.
    Tao Q; Wei L; Chang J; Wang H; Sun Y
    J Gastroenterol; 1998 Oct; 33(5):684-93. PubMed ID: 9773933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis.
    Enomoto N; Kurosaki M; Tanaka Y; Marumo F; Sato C
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1361-9. PubMed ID: 8207402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C.
    Kurosaki M; Enomoto N; Marumo F; Sato C
    Virology; 1994 Nov; 205(1):161-9. PubMed ID: 7975211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy.
    Chayama K; Suzuki F; Tsubota A; Kobayashi M; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Takahashi N; Kinoshita M; Kumada H
    Hepatology; 2000 Nov; 32(5):1138-44. PubMed ID: 11050067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.